193 related articles for article (PubMed ID: 23970376)
1. Role of the Hedgehog pathway in hepatocellular carcinoma (review).
Zheng X; Zeng W; Gai X; Xu Q; Li C; Liang Z; Tuo H; Liu Q
Oncol Rep; 2013 Nov; 30(5):2020-6. PubMed ID: 23970376
[TBL] [Abstract][Full Text] [Related]
2. Implication of the Hedgehog pathway in hepatocellular carcinoma.
Della Corte CM; Viscardi G; Papaccio F; Esposito G; Martini G; Ciardiello D; Martinelli E; Ciardiello F; Morgillo F
World J Gastroenterol; 2017 Jun; 23(24):4330-4340. PubMed ID: 28706416
[TBL] [Abstract][Full Text] [Related]
3. Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells.
Cheng WT; Xu K; Tian DY; Zhang ZG; Liu LJ; Chen Y
Int J Oncol; 2009 Mar; 34(3):829-36. PubMed ID: 19212688
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma.
Ding J; Li HY; Zhang L; Zhou Y; Wu J
Cells; 2021 Jan; 10(1):. PubMed ID: 33440657
[TBL] [Abstract][Full Text] [Related]
5. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
6. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
[TBL] [Abstract][Full Text] [Related]
7. Role of canonical Hedgehog signaling pathway in liver.
Gao L; Zhang Z; Zhang P; Yu M; Yang T
Int J Biol Sci; 2018; 14(12):1636-1644. PubMed ID: 30416378
[TBL] [Abstract][Full Text] [Related]
8. Blocking the hedgehog pathway inhibits hepatoblastoma growth.
Eichenmüller M; Gruner I; Hagl B; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
Hepatology; 2009 Feb; 49(2):482-90. PubMed ID: 19177589
[TBL] [Abstract][Full Text] [Related]
9. The molecular connection of histopathological heterogeneity in hepatocellular carcinoma: A role of Wnt and Hedgehog signaling pathways.
Tripathy A; Thakurela S; Sahu MK; Uthanasingh K; Behera M; Ajay AK; Kumari R
PLoS One; 2018; 13(12):e0208194. PubMed ID: 30513115
[TBL] [Abstract][Full Text] [Related]
10. Genomics and signaling pathways in hepatocellular carcinoma.
Villanueva A; Newell P; Chiang DY; Friedman SL; Llovet JM
Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
[TBL] [Abstract][Full Text] [Related]
11. Loss of cooperative function of transforming growth factor-beta signaling proteins, smad3 with embryonic liver fodrin, a beta-spectrin, in primary biliary cirrhosis.
Mishra B; Tang Y; Katuri V; Fleury T; Said AH; Rashid A; Jogunoori W; Mishra L
Liver Int; 2004 Dec; 24(6):637-45. PubMed ID: 15566516
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic high regulation of ATAD2 regulates the Hh pathway in human hepatocellular carcinoma.
Wu G; Lu X; Wang Y; He H; Meng X; Xia S; Zhen K; Liu Y
Int J Oncol; 2014 Jul; 45(1):351-61. PubMed ID: 24805933
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma.
Tada M; Kanai F; Tanaka Y; Tateishi K; Ohta M; Asaoka Y; Seto M; Muroyama R; Fukai K; Imazeki F; Kawabe T; Yokosuka O; Omata M
Clin Cancer Res; 2008 Jun; 14(12):3768-76. PubMed ID: 18559595
[TBL] [Abstract][Full Text] [Related]
14. Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer.
Philips GM; Chan IS; Swiderska M; Schroder VT; Guy C; Karaca GF; Moylan C; Venkatraman T; Feuerlein S; Syn WK; Jung Y; Witek RP; Choi S; Michelotti GA; Rangwala F; Merkle E; Lascola C; Diehl AM
PLoS One; 2011; 6(9):e23943. PubMed ID: 21912653
[TBL] [Abstract][Full Text] [Related]
15. Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays.
Nomura T; Morishita A; Jian G; Mimura S; Kato K; Nomura K; Tani J; Miyoshi H; Yoneyama H; Sakamoto T; Fujita K; Maeda E; Kobara H; Mori H; Iwama H; Masaki T
Oncol Rep; 2013 Nov; 30(5):2476-80. PubMed ID: 23970062
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
[TBL] [Abstract][Full Text] [Related]
17. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
[TBL] [Abstract][Full Text] [Related]
18. Indian Hedgehog links obesity to development of hepatocellular carcinoma.
Chong YC; Lim TE; Fu Y; Shin EM; Tergaonkar V; Han W
Oncogene; 2019 Mar; 38(12):2206-2222. PubMed ID: 30470823
[TBL] [Abstract][Full Text] [Related]
19. Intricacies of hedgehog signaling pathways: a perspective in tumorigenesis.
Kar S; Deb M; Sengupta D; Shilpi A; Bhutia SK; Patra SK
Exp Cell Res; 2012 Oct; 318(16):1959-72. PubMed ID: 22659135
[TBL] [Abstract][Full Text] [Related]
20. The hedgehog pathway in nonalcoholic fatty liver disease.
Verdelho Machado M; Diehl AM
Crit Rev Biochem Mol Biol; 2018 Jun; 53(3):264-278. PubMed ID: 29557675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]